Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Drug Resistance

Free Subscription Articles published in Infect Control Hosp Epidemiol Retrieve available abstracts of 29 articles: HTML format

Single Articles

May 2025
1. O'HARA LM, Calfee DP, Snyder GM, Martin EM, et al
   A discrete choice experiment to evaluate healthcare personnel preferences regarding risk-tailored policies for contact precautions for patients with methicillin-resistant Staphylococcus aureus.
   Infect Control Hosp Epidemiol. 2025 May 16:1-6. doi: 10.1017/ice.2025.
   PubMed     Abstract available
   
   
   
2. ROGOZIN E, Maree H, Masarwi M, Hasona R, et al
   Usage of oral vancomycin for acute Clostridioides difficile infection (CDI) resulting in later acquisitions of vancomycin-resistant enterococci (VRE).
   Infect Control Hosp Epidemiol. 2025 May 16:1-7. doi: 10.1017/ice.2025.
   PubMed     Abstract available
   
   
   April 2025
3. BOHJANEN S, Goldstick C, Hordinsky M
   Testing for methicillin-resistant Staphylococcus aureus in the anterior nares for antibiotic de-escalation in patients presenting with acute skin and soft tissue infections: systematic review and meta-analysis.
   Infect Control Hosp Epidemiol. 2025 Apr 16:1-5. doi: 10.1017/ice.2025.
   PubMed     Abstract available
   
   
   March 2025
4. JONES S, Stanton R, D'Angeli M, Brezak A, et al
   Community-associated New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales: multiple states, from September 2021 through September 2022.
   Infect Control Hosp Epidemiol. 2025 Mar 24:1-4. doi: 10.1017/ice.2025.
   PubMed     Abstract available
   
   
   February 2025
5. PRAKASH-ASRANI R, Bower C, Robichaux C, Chan B, et al
   Identifying patients at high risk for carbapenem-resistant Enterobacterales (CRE) carriage on admission to acute care hospitals: validating and expanding on a public health model.
   Infect Control Hosp Epidemiol. 2025 Feb 14:1-6. doi: 10.1017/ice.2025.
   PubMed     Abstract available
   
   
   January 2025
6. SANTOS CAQ, Won SY, Dwyer R, Perez C, et al
   Benchmarking antimicrobial use to antimicrobial resistance: a comparative study of two hospitals using current National Healthcare Safety Network (NHSN) metrics.
   Infect Control Hosp Epidemiol. 2025 Jan 27:1-8. doi: 10.1017/ice.2024.
   PubMed     Abstract available
   
   
   December 2024
7. WU CT, Shropshire WC, Bhatti MM, Cantu S, et al
   Rapid whole genome characterization of antimicrobial-resistant pathogens using long-read sequencing to identify potential healthcare transmission.
   Infect Control Hosp Epidemiol. 2024 Dec 27:1-7. doi: 10.1017/ice.2024.
   PubMed     Abstract available
   
   
   
8. KIM T, Moehring RW, Turner NA, Ashley ED, et al
   Long-term trends in the incidence of hospital-acquired carbapenem-resistant Enterobacterales and antimicrobial utilization in a network of community hospitals in the Southeastern United States from 2013 to 2023.
   Infect Control Hosp Epidemiol. 2024 Dec 3:1-7. doi: 10.1017/ice.2024.
   PubMed     Abstract available
   
   
   November 2024
9. LIM LL, Lim KWE, Malloy MJ, Bull A, et al
   Antimicrobial-resistant central line-associated bloodstream infections in adult intensive care units: findings from an Australian surveillance network, 2011-2022.
   Infect Control Hosp Epidemiol. 2024 Nov 7:1-7. doi: 10.1017/ice.2024.
   PubMed     Abstract available
   
   
   October 2024
10. KIRTZ EM, Chan A, McClanahan K, Octaria R, et al
    Leveraging multi-database linkages to assess racial and ethnic disparities among Carbapenem-resistant Enterobacterales cases in Tennessee, 2015-2019.
    Infect Control Hosp Epidemiol. 2024 Oct 2:1-7. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    July 2024
11. CINCOTTA SE, Walters MS, Ham DC, Octaria R, et al
    Regional impact of multidrug-resistant organism prevention bundles implemented by facility type: A modeling study.
    Infect Control Hosp Epidemiol. 2024;45:856-863.
    PubMed     Abstract available
    
    
    May 2024
12. VAIVOOTHPINYO S, Sathitakorn O, Jantarathaneewat K, Weber DJ, et al
    The impact of environmental cleaning protocol featuring PX-UV in reducing the incidence of multidrug-resistant gram-negative healthcare-associated infection and colonization in intensive care units in Thailand.
    Infect Control Hosp Epidemiol. 2024;45:684-687.
    PubMed     Abstract available
    
    
    April 2024
13. O'HARA LM, Harris AD, Calfee DP, Snyder GM, et al
    Healthcare personnel opinions regarding the feasibility of a risk-tailored approach to contact precautions for methicillin-resistant Staphylococcus aureus in the acute care setting.
    Infect Control Hosp Epidemiol. 2024 Apr 22:1-3. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    
14. CALISKAN G, Eren H, Aslan F, Tezgec N, et al
    Surveillance of carbapenem-resistant Klebsiella pneumoniae and Escherichia coli in perianal swab samples.
    Infect Control Hosp Epidemiol. 2024 Apr 12:1-4. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    March 2024
15. WANG L, Zeng C, Li X, Li Y, et al
    Mortality associated with carbapenem resistance in Klebsiella pneumoniae bloodstream infection: A propensity score-matched study.
    Infect Control Hosp Epidemiol. 2024 Mar 15:1-8. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    
16. ABIMANSOUR J, Martin JA, Petersen BT
    Implementation of multidrug-resistant bacterial testing to prioritize duodenoscope sterilization: Experience from a high-volume health system.
    Infect Control Hosp Epidemiol. 2024;45:397-399.
    PubMed    
    
    
    February 2024
17. CUI J, Heavey J, Lin L, Klein EY, et al
    Modeling relaxed policies for discontinuation of methicillin-resistant Staphylococcus aureus contact precautions.
    Infect Control Hosp Epidemiol. 2024 Feb 26:1-6. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    
18. FONTANA L, Hakki M, Ozer EA, Laird A, et al
    The impact of an intervention to reduce dispersal from wastewater drain sites on carbapenem-resistant Pseudomonas aeruginosa colonization and bloodstream infection on a hematopoietic cell transplant and hematologic malignancy unit.
    Infect Control Hosp Epidemiol. 2024 Feb 22:1-9. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    
19. HOWARD-ANDERSON JR, Gottlieb LB, Beekmann SE, Polgreen PM, et al
    Implementation of contact precautions for multidrug-resistant organisms in the post-COVID-19 pandemic era: An updated national Emerging Infections Network (EIN) survey.
    Infect Control Hosp Epidemiol. 2024 Feb 14:1-6. doi: 10.1017/ice.2024.
    PubMed     Abstract available
    
    
    January 2024
20. KISS CR, Ryan S, Meyer J, Kotsanas D, et al
    Impact of change in vancomycin-resistant Enterococcus infection prevention policy.
    Infect Control Hosp Epidemiol. 2024 Jan 22:1-2. doi: 10.1017/ice.2023.
    PubMed    
    
    
    
21. WARREN BG, Smith BA, Barrett A, Graves AM, et al
    Identification of carbapenem-resistant organism (CRO) contamination of in-room sinks in intensive care units in a new hospital bed tower.
    Infect Control Hosp Epidemiol. 2024 Jan 19:1-8. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    
22. ADEDIRAN TY, Robinson GL, Johnson JK, Liang Y, et al
    Factors associated with patient-to-healthcare personnel (HCP) and HCP-to-subsequent patient transmission of methicillin-resistant Staphylococcus aureus.
    Infect Control Hosp Epidemiol. 2024 Jan 18:1-7. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    December 2023
23. SIMON SJ, Sater M, Herriott I, Huntley M, et al
    Staphylococcus epidermidis joint isolates: Whole-genome sequencing demonstrates evidence of hospital transmission and common antimicrobial resistance.
    Infect Control Hosp Epidemiol. 2023 Dec 15:1-7. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    
24. HUYNH DN, Shah PJ, Greenlee SB, Long SW, et al
    Evaluation of computerized clinical decision support system to reduce unnecessary nasal methicillin-resistant Staphylococcus aureus (MRSA) polymerase chain reaction (PCR) testing.
    Infect Control Hosp Epidemiol. 2023 Dec 12:1-3. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    September 2023
25. BEN-DAVID D, Cohen Y, Levi G, Keren-Paz A, et al
    Contribution of active surveillance cultures to the control of hospital-acquired carbapenem-resistant Acinetobacter baumannii in an endemic hospital setting.
    Infect Control Hosp Epidemiol. 2023 Sep 20:1-8. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    
26. PETTIT NN, Nguyen CT, Lew AK, Pisano J, et al
    Impact of the sequential implementation of a pharmacy-driven methicillin-resistant Staphylococcus aureus (MRSA) nasal-swab ordering policy and vancomycin 72-hour restriction protocol on standardized antibiotic administration ratio (SAAR) data for anti
    Infect Control Hosp Epidemiol. 2023 Sep 13:1-5. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    July 2023
27. ROTHBERG MB, Haessler S, Deshpande A, Yu PC, et al
    Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia.
    Infect Control Hosp Epidemiol. 2023;44:1143-1150.
    PubMed     Abstract available
    
    
    June 2023
28. FARTHING TS, Jolley A, Nickel KB, Hill C, et al
    Early coronavirus disease 2019 (COVID-19) pandemic effects on individual-level risk for healthcare-associated infections in hospitalized patients.
    Infect Control Hosp Epidemiol. 2023 Jun 29:1-6. doi: 10.1017/ice.2023.
    PubMed     Abstract available
    
    
    December 2022
29. SCHWABER MJ, Temkin E, Lobl R, Schechner V, et al
    Hospital-acquired bacterial infections in coronavirus disease 2019 (COVID-19) patients in Israel.
    Infect Control Hosp Epidemiol. 2022 Dec 23:1-6. doi: 10.1017/ice.2022.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.